Speaker(s): 

Sara Gaines, PharmD, Hepatology MTM Pharmacist, Geisinger - has nothing to disclose.

Moderator(s): 

Leonie Vachon, NP, Western Region GI APP Chief, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

 -  Classify patients using AASLD’s new steatotic liver disease terminology

 -  Recognize medications newly approved to treat hepatologic conditions

  - Evaluate the appropriateness of these new medications in patient case

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Karla Leschinsky, PA-C, Leonie Vachon, CRNP, Hannah Clark, RN, Alyssa Jones, PharmD, and Lorella Thomas, CRNP have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None